The most definitively contraindicated drug in head injury is high-dose corticosteroids, specifically methylprednisolone. A landmark trial of over 10,000 patients proved that steroids increase the risk of death after traumatic brain injury by 15%. Beyond steroids, several other drug classes pose serious risks, including blood thinners, certain pain relievers, and medications that interfere with neurological monitoring.
Why Corticosteroids Are Contraindicated
For decades, doctors assumed that corticosteroids would help reduce brain swelling after a head injury. That changed after the MRC CRASH trial, one of the largest clinical trials ever conducted in head trauma. Researchers randomly assigned 10,008 adults with head injuries to receive either a 48-hour infusion of methylprednisolone or a placebo. The results were unambiguous: 25.7% of patients receiving steroids died, compared with 22.3% in the placebo group. The risk of death or severe disability was also higher in the steroid group.
These findings were so clear-cut that corticosteroids are now explicitly excluded from standard head injury management. The Brain Trauma Foundation’s guidelines, most recently updated in 2020, do not include steroids in the recommended treatment protocols for traumatic brain injury.
Blood Thinners and Bleeding Risk
Anticoagulants (blood thinners) are dangerous in the context of head injury because they promote or worsen intracranial bleeding. A patient already taking warfarin who suffers a head injury faces an in-hospital mortality rate of about 36.4%, compared with 16.8% for patients not on any blood-thinning medication. Newer blood thinners like rivaroxaban carry a similarly high mortality rate of 46.2% in this scenario.
Blood thinners are also an absolute contraindication if a stroke patient with recent head trauma needs clot-dissolving therapy. Giving clot-dissolving drugs to someone with a significant head injury within the previous three months is ruled out entirely because of the compounding risks: trauma patients often already have clotting problems, skull fractures and brain bruising create sites vulnerable to hemorrhage, and systemic injuries raise the chance of uncontrollable bleeding elsewhere in the body.
Opioids and Sedatives Mask Brain Injury Signs
Opioids like morphine and sedatives like benzodiazepines are not absolutely contraindicated in head injury, but they create a serious clinical problem. The Glasgow Coma Scale (GCS), the primary tool for assessing brain injury severity, relies on measuring eye opening, verbal responses, and motor responses. Opioids and sedatives suppress all three, making it impossible to tell whether a declining score reflects worsening brain damage or just the effect of the drug.
A study of 468 patients with blunt head trauma found that intoxicated patients (from drugs or alcohol) had significantly greater changes in their GCS scores once the substances wore off. Among patients with the lowest initial GCS score of 3, 150 out of 187 had a positive toxicology screen. Once sober, their scores improved by an average of 2.75 points, compared to only 1.19 points in sober patients. This means substances were artificially making their injuries appear far worse than they actually were, potentially leading to unnecessary invasive treatments or, conversely, delaying appropriate care if clinicians attributed the low score solely to intoxication.
Drugs That Lower the Seizure Threshold
Head injuries substantially increase the risk of seizures, both immediately and in the weeks that follow. Any medication that further lowers the seizure threshold becomes particularly risky in these patients. Several common drug classes fall into this category.
Tramadol, a widely prescribed pain reliever, is commonly associated with seizures both in overdose and at normal doses. Bupropion, an antidepressant also used for smoking cessation, has a clear dose-dependent relationship with seizure risk. Among antipsychotic medications, clozapine carries the highest seizure risk, followed by olanzapine and risperidone.
Certain antibiotics also pose a threat. Carbapenems (particularly imipenem), fluoroquinolones like ciprofloxacin, and even high-dose penicillins can interfere with the brain’s natural seizure-suppressing pathways. The bronchodilator theophylline, used for asthma, significantly reduces the seizure threshold as well. For head injury patients who need antibiotics or pain management, clinicians must choose alternatives that don’t compound their already elevated seizure risk.
NSAIDs and Platelet Function
Non-steroidal anti-inflammatory drugs like ibuprofen and aspirin are a concern after head injury because they interfere with platelet function, the body’s first line of defense against bleeding. Aspirin is the worst offender, irreversibly disabling platelet clotting ability for up to seven days. Other NSAIDs have a shorter, reversible effect lasting several hours, and research on post-surgical brain patients suggests their bleeding risk may be less clinically significant than once thought.
Still, in the acute phase of a head injury when intracranial bleeding is a primary concern, NSAIDs are generally avoided. They also carry a secondary risk: in animal models, aspirin, diclofenac, and indomethacin have all shown the ability to lower seizure thresholds in a dose-dependent fashion, compounding the seizure risk already present after brain trauma.
Ketamine: A Contraindication Reversed
Ketamine was considered contraindicated in head injury for decades based on early studies suggesting it raised intracranial pressure. This belief was so entrenched that by the 1990s, the drug was largely abandoned for use in brain-injured patients. Modern evidence tells a different story.
A systematic review of the available research found that none of the studies showed dangers from using ketamine in head trauma patients. Of seven selected papers, not one reported adverse events related to elevated intracranial pressure or increased mortality. A slight pressure increase appeared in only two studies, while two others actually showed a reduction in pressure. When ketamine is combined with a sedative that acts on GABA receptors (as is standard practice during anesthesia), it does not raise intracranial pressure at all. Some researchers now argue ketamine should be a first-choice drug for anesthesia induction in these patients, though the overall evidence grade remains moderate. After more than 50 years of research, ketamine appears to be underused rather than dangerous in brain trauma.
Medications That Worsen Brain Blood Flow
After a head injury, the brain is extremely sensitive to changes in blood pressure. Low blood pressure (below 90 mmHg systolic) starves the injured brain of oxygen and is treated aggressively with fluids. Medications that cause blood vessels to dilate can drop blood pressure or, paradoxically, increase pressure inside the skull by expanding blood vessels within the brain itself.
Dopamine, sometimes used to support blood pressure in critically ill patients, may raise intracranial pressure more than other options at equivalent blood pressure levels. Hypotonic (low-salt) intravenous fluids are also avoided because they can worsen brain swelling. Current guidelines favor isotonic or hypertonic fluids, along with specific medications like mannitol or hypertonic saline to manage cerebral edema, and anticonvulsants like levetiracetam to prevent early post-traumatic seizures.